---
title: GURJAOLAB – Research
layout: default
extra_css:
  - /research/research.css
---

<div class="research-page">
  <h1>Research</h1>

  <section class="research-section image-right">
    <div class="research-copy">
      <h2>What causes cancer mutations?</h2>
      <p class="lead">
        Every person’s tumour tells a story—our lifestyle habits, microbes, and immune system shape the tumour’s DNA and can leave marks. We aim to discover and study such marks to understand how cancer develops.
      </p>
      <p><em>Our discoveries so far:</em></p>
      <ul>
        <li><strong>Dietary habits:</strong> Discovered a mutational pattern linked to particular red-meat intake.</li>
        <li><strong>Susceptible subpopulations:</strong> Identified a group particularly prone to DNA damage from such habits.</li>
        <li><strong>Long-term effects:</strong> Assessed the impact of smoking on the colorectal cancer genome.</li>
      </ul>
      <p>In collaborations, we also assessed how alcohol and certain bacterial strains leave characteristic mutational marks.</p>
    </div>

    <div class="research-figure">
      <div class="img-frame">
        <img src="{{ '/research/fig-causes.png' | relative_url }}" alt="Factors shaping the mutational landscape">
      </div>
    </div>
  </section>

  <hr class="research-divider">

  <section class="research-section image-left">
    <div class="research-figure">
      <div class="img-frame">
        <img src="{{ '/research/fig-treatment.png' | relative_url }}" alt="Mutations informing therapy">
      </div>
    </div>

    <div class="research-copy">
      <h2>How can tumor mutations guide treatment?</h2>
      <p class="lead">
        Cancer immunotherapies are transforming treatment, yet not all patients respond the same way. Studying the mutational landscape of tumors can inform the best course of treatment and help predict aggressiveness.
      </p>
      <p><em>Our discoveries so far:</em></p>
      <ul>
        <li><strong>Resistance to immunotherapy:</strong> Identified intrinsic resistance to immune checkpoint blockade in mismatch-repair–deficient colorectal cancer.</li>
        <li><strong>Hidden cancers:</strong> Characterized interval colorectal cancers across multiple prospective cohorts.</li>
        <li><strong>Genetic context:</strong> Shown how specific contexts (e.g., RNF43/NTHL1) influence sensitivity to therapy.</li>
      </ul>
      <p>We also study how tumor cells evolve after treatment to refine precision oncology.</p>
    </div>
  </section>
</div>
